Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

Paragon Care Limited (PGC.AX)

Compare
0.4000
0.0000
(0.00%)
At close: April 4 at 4:10:37 PM GMT+11
Loading Chart for PGC.AX
  • Previous Close 0.4000
  • Open 0.3700
  • Bid 0.3850 x --
  • Ask 0.4000 x --
  • Day's Range 0.3700 - 0.4000
  • 52 Week Range 0.3100 - 0.5900
  • Volume 349,661
  • Avg. Volume 806,851
  • Market Cap (intraday) 662.124M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 40.00
  • EPS (TTM) 0.0100
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 18, 2023
  • 1y Target Est 0.54

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. It operates through two segments: ParagonCare and CH2. The company offers its for aesthetics, controlle, critical care, diagnostic and scientific, eye care, medical products and consumables, neonatal, orthopaedics service, surgical, technology & connectivity, urology, and veterinary products. It also involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. Paragon Care Limited is based in Mount Waverley, Australia.

www.paragoncare.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PGC.AX

View More

Performance Overview: PGC.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

PGC.AX
16.67%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

PGC.AX
23.08%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

PGC.AX
0.99%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

PGC.AX
246.38%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: PGC.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PGC.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    662.12M

  • Enterprise Value

    940.36M

  • Trailing P/E

    32.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    2.13

  • Enterprise Value/Revenue

    0.20

  • Enterprise Value/EBITDA

    11.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.43%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.38B

  • Net Income Avi to Common (ttm)

    14.49M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.66M

  • Total Debt/Equity (mrq)

    96.44%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PGC.AX

View More

Company Insights: PGC.AX

Research Reports: PGC.AX

View More

People Also Watch